Jenburkt Pharmaceuticals Ltd — Updates, 10-04-2025: Company Update

Jenburkt Pharmaceuticals Ltd. has submitted a certificate confirming compliance with SEBI regulations regarding the dematerialization of securities for the quarter ended 31st March 2025. The certificate, issued by Bigshare Services Pvt. Ltd., indicates that all securities received for dematerialization have been appropriately processed and listed, ensuring adherence to operational protocols.

This update reflects the company's commitment to maintaining transparency and regulatory compliance, which could bolster investor confidence. Overall, this move may present a positive outlook, reinforcing the company's governance and operational integrity in the eyes of shareholders.